Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways

by Liang-Pu Luo, Liang-Pu Luo, Ping Suo, Li-Li Ren, Hong-Jiao Liu, Yamei Zhang, Ying-Yong Zhao
Published 2021-12-01

Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

by Xiao-Jun Li, Xiao-Jun Li, Ping Suo, Yan-Ni Wang, Liang Zou, Xiao-Li Nie, Ying-Yong Zhao, Hua Miao
Published 2024-03-01

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis

by Shan-Shan Li, Shan-Shan Li, Qian Sun, Qian Sun, Meng-Ru Hua, Ping Suo, Jia-Rong Chen, Xiao-Yong Yu, Ying-Yong Zhao
Published 2021-08-01

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

by Yan-Ni Wang, Hong-Jiao Liu, Li-Li Ren, Ping Suo, Liang Zou, Ya-Mei Zhang, Xiao-Yong Yu, Ying-Yong Zhao, Ying-Yong Zhao, Ying-Yong Zhao
Published 2022-08-01

Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus.

by Lin-Lin Jia, Yu-Ming Kang, Fu-Xin Wang, Hong-Bao Li, Yan Zhang, Xiao-Jing Yu, Jie Qi, Yu-Ping Suo, Zhen-Jun Tian, Zhiming Zhu, Guo-Qing Zhu, Da-Nian Qin
Published 2014-01-01